跳至主要内容
临床试验/JPRN-UMIN000015385
JPRN-UMIN000015385已完成未知

The effect of miglitol on glucose, blood pressure, and heart rate variability in patients with type 2 diabetes. - Miglitol cardiovascular glycemic variability study

Jichi Medical University School of Medicine0 个研究点目标入组 20 人开始时间: 2014年10月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with significant arrhythmia such as atrial fibrilation. 2. Patients with decompensated heart failure, fever, inflammation (CRP>1.0mg/dl) 3. Patients who are using insulin 4. Hepatic damage (AST, ALT >100 IU/L) 5. Patients with HBV, or HCV infection 6. Moderate renal dysfunction (serum creatinine >2.0mg/dl) 7. Patients with inflammatory bowel disease, colon ulcer, and bowel obstruction. 8. Severe chronic bowel diseases 9. Patients who have disease with increased bowel gas. 10. Patients with a history of gastric resection. 11. Lactose intolerance 12. Pregnant women or possible pregnancy. 13. Contraindication for miglitol 14. Dementia from whom we cannot obtain informed consent. 15. For whom the attending doctor considered he or she is not appropriate for the study.

研究者

发起方
Jichi Medical University School of Medicine

相似试验

The effect of miglitol on glucose, blood pressure,... | 临床试验